Current Report Filing (8-k)
30 April 2022 - 6:01AM
Edgar (US Regulatory)
0001574235
false
--12-31
0001574235
2022-04-28
2022-04-28
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): April 28, 2022
PULMATRIX,
INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
001-36199 |
|
46-1821392 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
99
Hayden Avenue, Suite 390
Lexington,
MA 02421
(Address
of principal executive offices) (Zip Code)
(781)
357-2333
(Registrant’s
telephone number, including area code)
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications
pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of exchange
on
which registered |
Common
Stock, par value $0.0001 per share |
|
PULM |
|
The
NASDAQ Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
April 28, 2022, the board of directors of Pulmatrix, Inc. (the “Company”) approved an amendment to the Company’s existing
bylaws (the “Amendment”), effective as of April 28, 2022. The Amendment amends and restates Article I, Section 4 of the Company’s
existing bylaws in its entirety to lower the number of holders of the shares entitled to vote at a meeting of stockholders constituting
a quorum, in person or by proxy, from a majority to one-third. Specifically, the restated Section 4 states that “[a]t any meeting
of the stockholders, the holders of one-third of the voting power of all of the shares of the stock entitled to vote at the meeting,
present in person or by proxy, shall constitute a quorum for all purposes, unless or except to the extent that the presence of a larger
number may be required by law or by rules of any stock exchange upon which the Corporation’s securities are listed. Where a separate
vote by a class or classes is required, one-third of the voting power of the shares of such class or classes present in person or represented
by proxy shall constitute a quorum entitled to take action with respect to that vote on that matter. If a quorum shall fail to attend
any meeting, the chairman of the meeting may adjourn the meeting to another place, if any, date, or time.”
The
foregoing description of the Amendment is qualified by reference to the Amendment, a copy of which is attached hereto as Exhibit 3.1
and is incorporated herein by reference.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
PULMATRIX, INC. |
|
|
|
Date: April 29, 2022 |
By: |
/s/
Teofilo Raad |
|
|
Teofilo Raad |
|
|
Chief Executive Officer |
Pulmatrix (NASDAQ:PULM)
Historical Stock Chart
From Mar 2025 to Apr 2025
Pulmatrix (NASDAQ:PULM)
Historical Stock Chart
From Apr 2024 to Apr 2025